Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

10.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.3K
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

9.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.2K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

120
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
120
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immediate Background Color Choice in Male and Female <i>Poecilia reticulata</i>.

Animals : an open access journal from MDPI·2026
Same author

Optimizing the Priming Process for Hemoadsorption Combined with Hemodialysis (HAHD): A Two-Stage In Vitro and Clinical Validation Study.

Blood purification·2026
Same author

Bacterial extracellular vesicles exhibit distinct functional potential across biogeographic provinces of the South Pacific Ocean.

The ISME journal·2026
Same author

Robotic traction-assisted en bloc endoscopic resection of a large laterally spreading tumor in the descending duodenum.

Endoscopy·2026
Same author

Biphasic microgel-based bioinks with balanced printability, mechanical stability, and cytocompatibility for extrusion-based bioprinting.

International journal of biological macromolecules·2026
Same author

Naming learner agency at the bedside: FPTAL (from passive reception to active learning) as a dialogic bridge.

Academic medicine : journal of the Association of American Medical Colleges·2026

Related Experiment Video

Updated: Apr 30, 2026

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

1.1K

A multi-target drug design method based on target feature fusion.

Haoran Liu1, Xiaoli Lin1, Jing Hu1

  • 1Hubei Key Laboratory of Intelligent Information Processing and Real-Time Industrial System, School of Computer Science and Technology, Wuhan University of Science and Technology, Wuhan, Hubei, China.

BMC Bioinformatics
|April 29, 2026
PubMed
Summary

This study introduces a novel protein feature fusion method for designing multi-target drugs, enhancing therapeutic efficiency for diseases like COVID-19 and cancer. The approach efficiently creates drugs with strong binding affinities for multiple protein targets.

Keywords:
Deep learningDrug designMolecular docking

More Related Videos

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

3.4K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.5K

Related Experiment Videos

Last Updated: Apr 30, 2026

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

1.1K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

3.4K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.5K

Area of Science:

  • Computational drug discovery
  • Medicinal chemistry
  • Bioinformatics

Background:

  • Targeted drugs offer precise disease treatment by acting on specific cellular sites.
  • Multi-target drugs enhance therapeutic efficiency but present significant design challenges.
  • Current multi-target drug design methods, often optimizing single-target drugs, have inherent limitations.

Purpose of the Study:

  • To propose an efficient multi-target drug design method using protein feature fusion.
  • To enable the design of drugs targeting multiple proteins without prior drug knowledge.
  • To improve upon existing limitations in multi-target drug development.

Main Methods:

  • Encoding and integrating protein sequence features using embedding techniques.
  • Independently encoding individual target features into latent vectors.
  • Encoding multiple target features into similarity latent vectors for comprehensive design.

Main Results:

  • Validated the method on diverse target groups: COVID-19 (3CLpro/PLpro), schizophrenia (TAAR1/DRD2), and tumors (MEK1/mTOR).
  • Designed multi-target drugs demonstrated effective docking with unique protein structures and target pockets.
  • The molecular fit confirmed the method's efficacy in designing drugs for multiple targets.

Conclusions:

  • The proposed method efficiently designs multi-target drugs with superior predicted binding affinities.
  • Developed drugs exhibit adaptability to multiple targets based on protein feature analysis.
  • The model shows strong generalization capabilities for novel, multiple targets.